03:25 AM EDT, 09/13/2024 (MT Newswires) -- Saurabh Saha, Director, Chief Executive Officer, on September 10, 2024, sold 175,000 shares in Centessa Pharmaceuticals ( CNTA ) for $2,891,823. Following the Form 4 filing with the SEC, Saha has control over a total of 814,924 shares of the company, with 776,924 shares held directly and 38,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1847903/000184790324000142/xslF345X05/wk-form4_1726185660.xml